Dataset Information

The role of metal nanoparticles in the pathogenesis of stone formation

ABSTRACT: The present work is devoted to the study of morphology and composition of stones obtained as a result of surgical interventions for sialolithiasis The obtained results of clinical and laboratory studies allow us to broaden the view on the pathogenesis of stone formation and suggest that the occurrence of calcification of antigenic structures may be associated with the formation of IgG4 associated disease..

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Tooth

SUBMITTER: Nikita Polyakov

LAB HEAD: Nikita Polyakov

PROVIDER: PXD054153 | Pride | 2025-05-07

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	Stones_CNBr_2_Slot1-13_1_5218.mgf	Mgf
	Stones_CNBr_2_Slot1-13_1_5218.mzML	Mzml
	Stones_CNBr_3_Slot1-14_1_5220.mgf	Mgf
	Stones_CNBr_3_Slot1-14_1_5220.mzML	Mzml
	Stones_CNBr_5_Slot1-15_1_5222.mgf	Mgf

Items per page:

1 - 5 of 16

Publications

The Role of Metal Nanoparticles in the Pathogenesis of Stone Formation.

Labis Varvara V Gaiduk Igor I Bazikyan Ernest E Khmelenin Dmitry D Zhigalina Olga O Dyachkova Irina I Zolotov Denis D Asadchikov Victor V Kravtsov Ivan I Polyakov Nikita N Solovyev Andrey A Prusakov Kirill K Basmanov Dmitry D Kozlov Ivan G IG

International journal of molecular sciences 20240905 17

The process of stone formation in the human body remains incompletely understood, which requires clinical and laboratory studies and the formulation of a new endogenous, nanotechnological concept of the mechanism of origin and formation of crystallization centers. Previously, the mechanism of sialolithiasis was considered a congenital disease associated with the pathology of the ducts in the structure of the glands themselves. To date, such morphological changes of congenital nature can be consi ...[more]

PMID: 39273555

Similar Datasets

Project description:Introduction. At present, the precise role of Spry proteins in tumor progression is still debated. Our previous study showed that Spry1 knockdown (Spry1KO) in BRAFV600-mutant cutaneous melanoma (CM) promoted cell cycle arrest and apoptosis, repressed cell proliferation in vitro, and reduced tumor growth in vivo. Furthermore, we observed that Spry1 loss impaired angiogenesis in vivo. Hypoxia has been recognized as one of the crucial features of CM. Hypoxia results in the activation of the transcription factor hypoxia-inducible factor 1α (HIF‐1α), which represents a master regulator of angiogenesis. Hence, the present study was designed to explore a possible role of Spry1 in modulating angiogenesis and hypoxia in CM. Materials and methods. SPRY1 gene was knocked-out using the CRISPR strategy in the BRAF wild-type (wt) Mel 313 and in the BRAF-mutant Mel 593 cell lines. Angiogenic potential was assessed through in vivo CD31 staining and in vitro tube formation assays. By using in vitro and in vivo models, the effects of Spry1KO on hypoxia-related genes were investigated through RNA-sequencing (RNA-seq), quantitative real-time PCR, western blot, and immunofluorescence analyses. To gain insight into Spry1 interactome, immunoprecipitation coupled to mass spectrometry (IP-MS) was employed. Results and discussion. Consistent with our previous data, tumors arising from Mel 313 and Mel 593 Spry1KO clones were significantly smaller than those from their corresponding parental cells. Tumor growth inhibition was accompanied by a substantial reduction of angiogenesis, as assessed by the immunofluorescence staining of CD31 in vivo and the tube formation assay in vitro. Accordingly, RNA-seq analysis indicated that the vascular endothelial growth factor A was significantly down-regulated following Spry1 silencing. Notably, Ingenuity Pathway Analysis identified “HIF-1α Signaling” as the most significant molecular and cellular function affected in vivo by Spry1 silencing regardless of the BRAF mutational status. Analyses of tumor tissues confirmed that Spry1KO significantly reduced HIF1-α protein abundance. Interestingly, HIF-1α mRNA levels were minimally affected, thus suggesting that Spry1KO might impact on HIF-1α expression post-translationally. IP-MS identified about 50 Spry1 protein partners, and most of them were mitochondrial. Importantly, western blot analysis of cytosolic and mitochondrial proteins revealed that Spry1 was largely expressed in CM cell lines irrespective of BRAF mutation. Conclusions. Altogether, these data lead us to speculate that Spry1 might play a role in mitochondria homeostasis, thus impacting on hypoxia and angiogenesis in CM.